Anti-Clathrin Heavy Chain / CHC Reference Antibody (Academia Sinica patent anti-Clathrin Heavy Chain)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Conjugation | Unconjugated |
Anti-Clathrin Heavy Chain / CHC Reference Antibody (Academia Sinica patent anti-Clathrin Heavy Chain)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Conjugation | Unconjugated |
Anti-CLEC4C Reference Antibody (BIIB059)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-Amyloid Alpha Reference Antibody (birtamimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Anti-Amyloid Beta Reference Antibody (aducanumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse, Cynomolgus |
Conjugation | Unconjugated |
Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (urelumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-IL-6 / IFNb2 Reference Antibody (sirukumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Conjugation | Unconjugated |
Anti-IL-6 / IFNb2 Reference Antibody (Chugai SK2)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Conjugation | Unconjugated |
Anti-IL-6 / IFNb2 Reference Antibody (MEDI 5117)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-NKG2D / CD314 Reference Antibody (tesnatilimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-NRP1 / VEGF165R / CD304 Reference Antibody (vesencumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (cudarolimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (tavolixizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (serplulimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (cemiplimab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |